Concepedia

Taeko Hayakawa

TH

Statistics

Publications

6

Citations

198

H-Index

6

Active since

2014

Affiliations

Keio University(Current)

Kyushu University

Tokyo University of Science

Taeko Hayakawa is an author at Keio University specializing in oncology, checkpoint inhibitor therapy, and immune checkpoint inhibitors.

ORCID

Publications per year

2014–2024

6

Publications

6

Enhanced anti‐tumor effects of the PD‐1 blockade combined with a highly absorptive form of curcumin targeting STAT3

Taeko Hayakawa, Tomonori Yaguchi, Yutaka Kawakami · Cancer Science · 2020 · 72 citations · Full text

, , +17

NR4a1/2 deletion promotes accumulation of TCF1+ stem-like precursors of exhausted CD8+ T cells in the tumor microenvironment

Tanakorn Srirat, Taeko Hayakawa, Setsuko Mise‐Omata et al. · Cell Reports · 2024 · 44 citations · Full text

, , +17

NR4A ablation improves mitochondrial fitness for long persistence in human CAR-T cells against solid tumors

Kensuke Nakagawara, Makoto Ando, Tanakorn Srirat et al. · Journal for ImmunoTherapy of Cancer · 2024 · 36 citations · Full text

, , +17

SOCS3 deletion in effector T cells confers an anti-tumorigenic role of IL-6 to the pro-tumorigenic cytokine

Setsuko Mise‐Omata, Makoto Ando, Tanakorn Srirat et al. · Cell Reports · 2023 · 17 citations · Full text

, , +17

The Nr4a family regulates intrahepatic Treg proliferation and liver fibrosis in MASLD models

Daisuke Aki, Taeko Hayakawa, Tanakorn Srirat et al. · Journal of Clinical Investigation · 2024 · 16 citations · Full text

, , +17

1–5 of 6